Leaderboard

En | De
Sie sind hier: Gynäkologie 29. September 2026
Suchen
medline.ch
Gynäkologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Fortpflanzung
Genitale Erkrankungen
Infertilität
Mammae
Menopause
Schwangerschaft
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 14343  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 286858  
   
Circulating tumour DNA and its clinical relevance in predicting progression-free survival and overall survival in patients with advanced breast cancer: a systematic review and meta-analysis.
Breast Cancer Res Treat
Ottosen C, Kragelund E, Pedersen MA, Nguyen VQ, Khan SK, Larsen HB, Møller AL, Gamborg-Kvist SH, Spindler KG, Brems-Eskildsen AS, Callesen LB.
PMID: 42804029 [PubMed - indexed for MEDLINE]


Dermatologic adverse events associated with Sacituzumab Govitecan: an international retrospective study from the EADV Task Force "Dermatology for Cancer Patients" and pharmacovigilance analysis.
Breast Cancer Res Treat
Koumprentziotis IA, Cawley A, Ewig E, Gérard AO, Labat M, Kami, Kubeczko M, Rapparini L, Starace M, Grafanaki K, Kamaratou M, Mavroudis D, Katoulis A, Nikolaou V, Heelan K, Koumaki D.
PMID: 42804021 [PubMed - indexed for MEDLINE]


Animal reproduction in the tropics and subtropics: matching innovation with resilience and reality.
Trop Anim Health Prod
Bianchi CP, Dávila FS, Adnane M, Choudhary S, Ungerfeld R.
PMID: 42804017 [PubMed - indexed for MEDLINE]


Association of miR-199a-3p and CDK7 expression with clinicopathological features of breast cancer.
Mol Biol Rep
Ibrahim NA, Hidayat HJ.
PMID: 42804014 [PubMed - indexed for MEDLINE]


HER2 status change in residual breast carcinoma after neoadjuvant HER2-targeted therapy in patients with HER2-positive breast cancer.
Breast Cancer Res Treat
Raval P, Ding Q, Singh P, Alrohaibani A, Sun H, Ai D, Wanis KN, Zhao M, Chen H, Valero V, Chavez-MacGregor M, Sahin A.
PMID: 42803995 [PubMed - indexed for MEDLINE]


Geographic access to triple negative breast cancer clinical trials: are trials located near patients?
Breast Cancer Res Treat
Amin LB, Kirkwood MK, Levit LA, Balogh EP, Waterhouse DM, Unger JM, Garrett-Mayer E, Chavez-MacGregor M.
PMID: 42803985 [PubMed - indexed for MEDLINE]


Pregnancy Outcome After First-Trimester Exposure to Statins: Study Results Based on the Embryotox Cohort.
Pharmacoepidemiol Drug Saf
Beck E, Adelsberger AT, Dathe K.
PMID: 42803717 [PubMed - indexed for MEDLINE]


Molecular insights into triazole-based compounds for triple-negative breast cancer treatment.
J Enzyme Inhib Med Chem
Vilangalil A, E S SP, Bukke SPN, V S, Meha N, Thalluri C, Daniel K, Ahikiriza AA.
PMID: 42803315 [PubMed - indexed for MEDLINE]


The miR-877-3p polymorphism rs1264440 is associated with susceptibility to breast cancer.
Ann Agric Environ Med
Gong W, Yu M, Han J, Wang X, Mao X.
PMID: 42802969 [PubMed - indexed for MEDLINE]


Prenatal allostatic load and adverse pregnancy outcomes: a systematic review and meta-analysis.
PeerJ
Zhao M, Zheng H, Qi D, Zhang X, Ba L, Wang B, Hong X.
PMID: 42802863 [PubMed - indexed for MEDLINE]


Divergent effects of hyperandrogenemia on the female reproductive neuroendocrine axis under different physiological conditions.
J Neuroendocrinol
Rose L, Kauffman AS.
PMID: 42802656 [PubMed - indexed for MEDLINE]


Mapping Breast Cancer Screening Publications in Palestine: A Scoping Review of Barriers and Facilitators.
Psychooncology
Yaish M, Khursani A, Althaher I, Hijazi M, Subeh H, Hanani A.
PMID: 42802496 [PubMed - indexed for MEDLINE]


Hereditary breast cancer: emerging roles of non-coding RNAs.
Hereditas
Yang Z, Guha D, Zhang L, Diao H, Bagchi A.
PMID: 42802225 [PubMed - indexed for MEDLINE]


Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial.
Nat Commun
Wang J, Ouyang Q, Xie W, Niu Z, Zhang Q, Yan X, Teng Y, Chang J, Cheng Y, Wang A, Wang J, Yao H, Yang Z, Sun T, Tong Z, Wu X, Wang Y, Zhou E, Kong X, Wang X, Zeng D, Gu S, Hou Y, Gao D, Qu Z, Han C, Fang J, Xu B.
PMID: 42802176 [PubMed - indexed for MEDLINE]


Initial peripherally inserted central catheter tip position accuracy by puncture arm and associated factors in female patients with breast cancer: A retrospective cohort study.
J Int Med Res
Zhang M, Liu X, Ruan L, Pei X, Bi Q.
PMID: 42802165 [PubMed - indexed for MEDLINE]


Preoperative PIV and HALP: Correlation with Breast Cancer Pathology and Predictive Value for Microsatellite Status.
Iran J Allergy Asthma Immunol
Dong L, Zhao Y, Sun Y, Cui F.
PMID: 42801780 [PubMed - indexed for MEDLINE]


Advances in Drug Delivery Systems for Breast Cancer: From Microenvironment Barriers and Smart Carriers to Clinical Translation Strategies.
Drug Des Devel Ther
Liang G, Zhu C, Sun H, Ji Y, Jiang H.
PMID: 42801248 [PubMed - indexed for MEDLINE]


Pregnancy outcomes in women with rheumatologic diseases and neurologic involvement.
Rheumatol Int
Korn TF, Manzano GS, Clark MW, Bhattacharyya S, Houtchens MK.
PMID: 42799774 [PubMed - indexed for MEDLINE]


Development and validation of a risk prediction model for postoperative frailty in breast cancer patients.
PeerJ
Zhou Y, Li L, Jiang L, Zhou L, Qiu H.
PMID: 42799450 [PubMed - indexed for MEDLINE]


Progress of siRNA Nanomedicines in Modulating the Microenvironment of Triple-Negative Breast Cancer.
Int J Nanomedicine
Long Y, Yin H, Li J, Zhang W.
PMID: 42799209 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 286858    Seite 1 von 14343  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1